Citius Oncology CTOR
NASDAQ CTOR
$0.94 +0.01 (+1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026)

Citius Oncology's (CTOR) quarterly Interest & Investment Income came in at $96848.0 in Q2 2026, up 121.51% quarter-over-quarter from $43721.0 in Q1 2026.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026) Analysis & Trends

Citius Oncology (CTOR) has reported Interest & Investment Income for 2 consecutive years, with $96848.0 the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -48.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 48.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 67.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 28.14 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 36.92 Mn
10 Citius Oncology 101.41 Mn 101.41 Mn 1.00 Mn 96,848.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96,848.00
Mar 31, 2026 43,721.00
Dec 31, 2025 28,288.00